跳至主要内容
临床试验/NCT01148186
NCT01148186终止4 期

The Patient as a Driver of Change: an Intervention Study to Reduce the Use and Impact of Potentially Inappropriate Medications Among Older Adults

Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2010年6月1日最近更新:
适应症

试验速览

阶段
4 期
状态
终止
发起方
入组人数
300
试验地点
2
主要终点
Complete discontinuation of the targeted potentially inappropriate medication (e.g. benzodiazepines, oxybutynin)

研究概览

简要总结

An educational intervention targeting community-dwelling older adults will lead to a reduction in potentially inappropriate prescriptions (e.g. benzodiazepines, oxybutynin).

Cessation of potentially inappropriate medications (e.g. benzodiazepines, oxybutynin)will lead to improved cognitive outcomes in older adults.

详细描述

This study tests the effectiveness of a knowledge transfer tool for empowering patients to engage in collaborative discontinuation of potentially inappropriate medication with their pharmacist and/or physician

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • 65 year old human adults
  • who fill a prescription for at least 5 medications
  • community dwelling
  • chronic use (3 months or longer) of at least one potentially inappropriate medication (e.g. benzodiazepine, oxybutynin)

排除标准

  • patients with severe mental illness, dementia and epilepsy
  • concomitant consumption of any other antipsychotic medication (including lithium, olanzapine, clozapine, quetiapine, risperidone, haloperidol etc.)
  • concomitant consumption of any antiepileptic (including carbamazepine, valproate, gabapentin, lamotrigine, topiramate, oxcarbazepine etc.)
  • concomitant consumption of a cholinesterase inhibitor or memantine

结局指标

主要结局

Complete discontinuation of the targeted potentially inappropriate medication (e.g. benzodiazepines, oxybutynin)

时间窗: 6 months post-intervention

次要结局

  • Cognitive function(6-months post-intervention)
  • Sleep efficiency(6-months)
  • incontinence-related self-efficacy(6-months post-intervention)
  • frequency of urinary incontinence episodes(6-months post-intervention)

研究者

发起方
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
申办方类型
Other
责任方
Principal Investigator
主要研究者

Cara Tannenbaum

Dr.

Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal

研究点 (2)

Loading locations...

相似试验